The International Diabetes Federation (IDF) projects a continual rise in diabetes cases, estimating over 460 million people affected globally as of 2020. This expanding patient base underscores a growing market for diabetes-related medications and technologies.
The onset of Type 2 diabetes in younger demographics, including children and adolescents, is shifting the landscape, creating a need for long-term treatment solutions and patient education
What is Vilbay M?
Vilbay M is a medication used to manage type 2 diabetes. It combines two active ingredients: Vildagliptin 50mg and Metformin 500mg. Vildagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, while metformin is a biguanide. This combination helps control blood sugar levels by targeting different mechanisms in the body.
How Does Vilbay M Work?
Vilbay M works in two ways to help manage type 2 diabetes:
By combining these two medications, Vilbay M provides a dual-action approach to managing type 2 diabetes, helping to improve overall glycemic control.
Benefits of Vilbay M
Talk to your Doctor to learn more about Vilbay M
REUEL PHARMACEUTICALS
52/3216 - A Vembully Lane, Vyttila, Cochin, Ernakulam, Kerala 682019 | Kootezhath Bldg, Kuvempu Layout, Hebbal-Kempapura, Bangalore-560024
Copyright © 2024 REUEL PHARMACEUTICALS - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.